دورية أكاديمية

Effect of blood pressure lowering on markers of kidney disease progression.

التفاصيل البيبلوغرافية
العنوان: Effect of blood pressure lowering on markers of kidney disease progression.
المؤلفون: Udani SM; Section of Nephrology, University of Chicago, Chicago, IL 60637, USA., Koyner JL
المصدر: Current hypertension reports [Curr Hypertens Rep] 2009 Oct; Vol. 11 (5), pp. 368-74.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Review
اللغة: English
بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100888982 Publication Model: Print Cited Medium: Internet ISSN: 1534-3111 (Electronic) Linking ISSN: 15226417 NLM ISO Abbreviation: Curr Hypertens Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Philadelphia, PA : Current Science, Inc., c1999-
مواضيع طبية MeSH: Antihypertensive Agents/*therapeutic use , Blood Pressure/*drug effects , Hypertension/*complications , Kidney Failure, Chronic/*physiopathology, Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Biomarkers ; Calcium Channel Blockers/therapeutic use ; Disease Progression ; Glomerular Filtration Rate ; Humans ; Hypertension/drug therapy ; Hypertension/physiopathology ; Kidney Failure, Chronic/drug therapy ; Kidney Failure, Chronic/prevention & control
مستخلص: Hypertension remains a common comorbidity and cause of chronic kidney disease (CKD). As the number of patients with CKD grows, so does the need to identify modifiable risk factors for CKD progression. Data on slowing progression of CKD or preventing end-stage renal disease with aggressive blood pressure control have not yielded definitive conclusions regarding ideal blood pressure targets. Shifting the focus of antihypertensive therapy to alternative markers of end-organ damage, specifically proteinuria, has yielded some promise in preventing the progression of CKD. Nevertheless, proteinuria and decline in estimated GFR may represent an irreversible degree of injury to the kidney that limits the impact of any therapy. The identification and use of novel markers of kidney injury to assess the impact of antihyper-tensive therapy may yield clearer direction with regard to optimal management of hypertension in the setting of CKD.
Number of References: 25
References: Arch Intern Med. 2008 Apr 28;168(8):832-9. (PMID: 18443258)
Arch Intern Med. 2005 Apr 25;165(8):923-8. (PMID: 15851645)
Clin J Am Soc Nephrol. 2009 Feb;4(2):337-44. (PMID: 19176795)
Curr Hypertens Rep. 2009 Oct;11(5):363-7. (PMID: 19737453)
N Engl J Med. 2001 Sep 20;345(12):851-60. (PMID: 11565517)
Kidney Int. 1995 Sep;48(3):851-9. (PMID: 7474675)
Lancet. 1997 Jun 28;349(9069):1857-63. (PMID: 9217756)
N Engl J Med. 1996 Jan 4;334(1):13-8. (PMID: 7494564)
Am J Hypertens. 2007 Oct;20(10):1092-6. (PMID: 17903693)
Arch Intern Med. 2003 Jul 14;163(13):1555-65. (PMID: 12860578)
Kidney Blood Press Res. 2009;32(2):91-8. (PMID: 19321980)
N Engl J Med. 2005 May 19;352(20):2049-60. (PMID: 15901858)
Drugs. 2005;65 Suppl 2:1-10. (PMID: 16398057)
Arch Intern Med. 2005 Apr 25;165(8):947-53. (PMID: 15851648)
Am J Kidney Dis. 2001 Jan;37(1):79-83. (PMID: 11136171)
Clin Ther. 2008 Mar;30(3):482-98. (PMID: 18405787)
Ann Intern Med. 1995 Nov 15;123(10):754-62. (PMID: 7574193)
N Engl J Med. 2001 Sep 20;345(12):861-9. (PMID: 11565518)
Am J Hypertens. 2006 Sep;19(9):939-46. (PMID: 16942937)
J Am Soc Nephrol. 2009 Apr;20(4):883-92. (PMID: 19225038)
N Engl J Med. 1994 Mar 31;330(13):877-84. (PMID: 8114857)
JAMA. 2002 Nov 20;288(19):2421-31. (PMID: 12435255)
Am J Kidney Dis. 2005 Feb;45(2):281-7. (PMID: 15685505)
BMJ. 1998 Sep 12;317(7160):703-13. (PMID: 9732337)
Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1347-55. (PMID: 19018688)
معلومات مُعتمدة: K23 DK081616-01A1 United States DK NIDDK NIH HHS
المشرفين على المادة: 0 (Angiotensin II Type 1 Receptor Blockers)
0 (Angiotensin-Converting Enzyme Inhibitors)
0 (Antihypertensive Agents)
0 (Biomarkers)
0 (Calcium Channel Blockers)
تواريخ الأحداث: Date Created: 20090910 Date Completed: 20100929 Latest Revision: 20211020
رمز التحديث: 20231215
DOI: 10.1007/s11906-009-0061-2
PMID: 19737454
قاعدة البيانات: MEDLINE